Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Praxis Precision Medicines (PRAX) Net Income (2022 - 2025)

Historic Net Income for Praxis Precision Medicines (PRAX) over the last 4 years, with Q3 2025 value amounting to -$78.4 million.

  • Praxis Precision Medicines' Net Income fell 3787.1% to -$78.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$293.1 million, marking a year-over-year decrease of 7870.93%. This contributed to the annual value of -$200.2 million for FY2024, which is 5839.22% down from last year.
  • Per Praxis Precision Medicines' latest filing, its Net Income stood at -$78.4 million for Q3 2025, which was down 3787.1% from -$76.1 million recorded in Q2 2025.
  • In the past 5 years, Praxis Precision Medicines' Net Income ranged from a high of -$25.5 million in Q3 2023 and a low of -$78.4 million during Q3 2025
  • For the 4-year period, Praxis Precision Medicines' Net Income averaged around -$51.4 million, with its median value being -$43.9 million (2022).
  • Per our database at Business Quant, Praxis Precision Medicines' Net Income soared by 4467.46% in 2023 and then crashed by 13000.79% in 2024.
  • Over the past 4 years, Praxis Precision Medicines' Net Income (Quarter) stood at -$41.5 million in 2022, then skyrocketed by 32.92% to -$27.8 million in 2023, then tumbled by 130.01% to -$64.0 million in 2024, then fell by 22.52% to -$78.4 million in 2025.
  • Its last three reported values are -$78.4 million in Q3 2025, -$76.1 million for Q2 2025, and -$74.7 million during Q1 2025.